2025. Efficacy of Neoadjuvant Endocrine Therapy Compared to Chemotherapy in ER+HER2-Negative Breast Cancer in Postmenopausal Patients: Preliminary Results of a Single-Center Matched-Cohort Study. Voprosy onkologii. 71, 3 (Jun. 2025), OF-2304. DOI:https://doi.org/10.37469/0507-3758-2025-71-3-OF-2304.